Sanofi epinephrine device guides users with voice and written instructions

Sanofi ($SNY) this week gained FDA approval for a new credit card-sized epinephrine/adrenaline injection device that gives aural and written instructions to users. The Auvi-Q combination device is about as thick as a cell phone and designed to treat allergic reactions, according to The Associated Press. It even retracts the needle to minimize accidental sticking. The treatment is meant to counter severe allergic reactions to things like medications, bee stings and foods like nuts or shellfish, the story notes. Story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.